<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">768153</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2021.768153</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Molecular Mechanisms of Voltage-Gating in Ion Channels</article-title>
<alt-title alt-title-type="left-running-head">Loussouarn and Tarek</alt-title>
<alt-title alt-title-type="right-running-head">Editorial: Molecular Mechanisms of Voltage-Gating</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Loussouarn</surname>
<given-names>Gildas</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/19117/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tarek</surname>
<given-names>Mounir</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/40965/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>L&#x27;Institut Du Thorax, Inserm UMR 1087/CNRS UMR 6291, <addr-line>Nantes</addr-line>, <country>France</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Universit&#xe9; de Lorraine, LPCT, CNRS UMR 7019, <addr-line>Nancy</addr-line>, <country>France</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/16577/overview">Michael Pusch</ext-link>, National Research Council (CNR), Italy</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Gildas Loussouarn, <email>Gildas.Loussouarn@univ-nantes.fr</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Frontiers in Pharmacology, a section of the journal Frontiers in Pharmacology of Ion Channels and Channelopathies</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>768153</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>09</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Loussouarn and Tarek.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Loussouarn and Tarek</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/researchtopic/10282" ext-link-type="uri">Editorial on the Research Topic <article-title>Molecular Mechanisms of Voltage-Gating in Ion Channels</article-title>
</related-article>
<kwd-group>
<kwd>voltage-gated ion channel</kwd>
<kwd>patch - clamp technique</kwd>
<kwd>toxins</kwd>
<kwd>cryo-EM</kwd>
<kwd>VSD gate coupling</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Voltage-gated ion channels are transmembrane proteins conducting ions according to the electrochemical gradient, when opened by voltage. Hence, in these channels, at least one of the channel gates regulating the ion flux is controlled by the transmembrane potential. They are frequently ion specific and therefore selectively permeable to sodium (Na<sub>V</sub> channels), potassium (K<sub>V</sub> channels), calcium (Ca<sub>V</sub> channels) or chloride (CLC channels) ions. Depending on the channels, opening of the activation gate is triggered by membrane depolarization (e.g. K<sub>V</sub>, Na<sub>V</sub> and Ca<sub>V</sub> channels) or hyperpolarization (HCN channels for instance). In addition, in many voltage-gated channels, a so-called inactivation gate is also present. Compared to the activation gate, the latter is, when voltage-dependent, oppositely coupled to the potential: In K<sub>V</sub>, Na<sub>V</sub> and Ca<sub>V</sub> channels, upon membrane depolarization, the inactivation gate closes whereas the activation gate&#x20;opens.</p>
<p>Various voltage-dependent channels have been identified, depending on the excitable cell types in which they are expressed and their physiological role. They are characterized by their conductance, ion selectivity, pharmacology and voltage-sensitivity. These properties are mainly dictated by the amino-acid sequence and structure of the pore forming subunit(s), the presence of accessory subunit(s), the membrane composition and the intra- and extracellular ions concentrations. Many mutations have been identified in these channels, impacting their functions and provoking diseases named channelopathies.</p>
<p>In 2012, we hosted a Research Topic on the Molecular Mechanisms of Voltage Dependency (<xref ref-type="bibr" rid="B2">Loussouarn and Tarek, 2012</xref>), bringing together scientists to collaborate and showcase the latest developments in the field. Since this Frontiers Research Topic, the development of new approaches, such as the use of cryo-electron microscopy (cryo-EM) at the atomic scale and the original approach of split channels, to name a few, has led to a more precise understanding of the mechanisms of voltage-gating, their targeting by toxins, and also their physio-pathological implications. Given the wealth of recent electrophysiological, biochemical, optical, and structural data regarding ion channel voltage-dependence, we felt there was clearly a need for putting together a new Research Topic that would include up to date Reviews and Original Research describing molecular details of the functioning of these complex voltage-gated channels.</p>
<p>The review of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00550">Brewer et&#x20;al.</ext-link> underlines how ion channel structures and models reveal critical differences in the atomic details of KCNQ1, hERG, and Na<sub>V</sub>1.5 structures associated with their distinct voltage-gating and implication in Long QT syndrome, and also their pharmacological profiles. Such structural data may help defining the pathogenicity of the hundreds of variants in absence of functional data. It also mentions an important point: Molecular Dynamics represents a useful tool in refining cryo-EM structures, which are often of lower resolution in the periphery of protein core structures.</p>
<p>Among the critical differences recapitulated by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00550">Brewer et&#x20;al.</ext-link>, cryo-EM was instrumental to reveal the presence of a variation in the overall organization of voltage-gated channels, which is the presence of a non-domain-swapped <italic>vs.</italic> a domain-swapped structure. The non-domain-swapped structure (in which the voltage sensor of subunit A leans against the pore-forming helices of subunit A, B against B, etc.) first identified in K<sub>V</sub>10.1 channel and confirmed in hERG/K<sub>V</sub>11.1 has a major molecular impact: it prevents the role of the S4-S5 linker as a mechanical lever, and may explain why K<sub>V</sub>10.1 and K<sub>V</sub>11.1 channels, when artificially split at the level this S4-S5 linker, are still voltage-gated (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00411">Barros et&#x20;al.</ext-link>). These observations are greatly compatible with the ligand-receptor suggested by our work on K<sub>V</sub>10.2 and K<sub>V</sub>11.2 (<xref ref-type="bibr" rid="B4">Malak et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B3">Malak et&#x20;al., 2017</xref>). It remains puzzling then that such a ligand-receptor model also applies to the domain-swapped K<sub>V</sub>7.1 channel (<xref ref-type="bibr" rid="B1">Choveau et&#x20;al., 2011</xref>), suggesting that key elements are still missing to understand the molecular mechanism of voltage gating.</p>
<p>Another article of our Research Topic also underlines the role of Structural Biology data, enriched by Molecular Dynamics, to confirm and refine the succession of electrostatic interactions of S4 residues with S1 to S3 countercharges during voltage-gated activation, and the role of voltage sensor domain (VSD) hydration in ion channel functioning (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00160">Groome and Bayless-Edwards</ext-link>). Importantly, some mutations of countercharges present in VSD are implicated in neural, cardiac and skeletal muscle disorders. For example, in hERG, mutation of these countercharges accelerates deactivation, slow deactivation being crucial for proper repolarization of the ventricular action potential (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00139">Shi et&#x20;al.</ext-link>). VSD also seems to play a role in hysteresis of channel gating. Hysteresis is a property of channel gating making it dependent on its &#x201c;history,&#x201d; resulting, for hERG, in a shifted voltage-dependence of deactivation towards hyperpolarized potentials as compared to the voltage-dependence of activation. Structural determinants of this property have been reviewed for hERG in <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00139">Shi et&#x20;al.</ext-link>, suggesting a contribution of both the S4-S5 linker and the VSD to hERG gating hysteresis. Hysteresis has been more generally and very didactically reviewed in <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.579596">Villalba-Galea and Chiem</ext-link>, including physiological implications. For instance, hysteresis prevents HCN activation during the repolarization phase of the sinoatrial node action potential.</p>
<p>Regarding voltage-gated channel modulators targeting hydrophobic binding sites, the review of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00735">Van Theemsche et&#x20;al.</ext-link> compiled the residues implicated in K<sub>V</sub> channel modulation by various lipophilic molecules. Mapping them on available structural data, they suggest three lipophilic drugs/toxin binding sites, a first step toward the classification of hydrophobic binding sites in the large and complex family of K<sub>V</sub> channels.</p>
<p>Finally, we are glad that our Research Topic motivated the submission of original articles. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00914">Kudaibergenova et&#x20;al.</ext-link> compared the molecular mechanisms of ivabradine and dofetilide block of hERG channel. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.01182">Li et&#x20;al.</ext-link> correlated the clinical response to mexiletine of LQT3 patients carrying various mutation on <italic>SCN5A</italic> (coding for Na<sub>V</sub>1.5), to the extent of inhibition of the late Na current by mexiletine, in cells expressing these mutated Na<sub>V</sub>1.5 channels. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.01091">Chang et&#x20;al.</ext-link>, described the off-target effect of remdesivir, an antiviral drug that was recently tested in SARS-CoV2 infected patients, on voltage-gated potassium currents present in pituitary tumor (GH3) and T lymphoblast (Jurkat) cells. Inwardly rectifying channels are not voltage-gated channels strictly speaking, but pore block by polyamines, the molecular mechanism of rectification in these channels, is a voltage-dependent process. For that reason and because tools are the same to study inwardly rectifying channels and voltage-gated channels, we also included a study that used Molecular Dynamics to get further insights on the mechanism of voltage dependent block by the polyamine putrescine (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2020.00721">Chen et&#x20;al.</ext-link>).</p>
</body>
<back>
<sec id="s1">
<title>Author Contributions</title>
<p>GL and MT wrote the manuscript.</p>
</sec>
<sec id="s2">
<title>Funding</title>
<p>GL is funded by the &#x201c;Fondation d&#x2019;entreprise Genavie.&#x201d;</p>
</sec>
<sec sec-type="COI-statement" id="s3">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s4">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choveau</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Abderemane Ali</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Labro</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dahim&#xe8;ne</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>KCNQ1 Channels Voltage Dependence through a Voltage-dependent Binding of the S4-S5 Linker to the Pore Domain</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>286</volume>, <fpage>707</fpage>&#x2013;<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.146324</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loussouarn</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tarek</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Mechanisms of Ion Channels Voltage-Dependency: All about Molecular Sensors, Gates, Levers, Locks, and Grease</article-title>. <source>Front. Pharmacol.</source> <volume>3</volume>, <fpage>174</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2012.00174</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malak</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Es-Salah-Lamoureux</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Loussouarn</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>hERG S4-S5 Linker Acts as a Voltage-dependent Ligand that Binds to the Activation Gate and Locks it in a Closed State</article-title>. <source>Sci. Rep.</source> <volume>7</volume>, <fpage>113</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-00155-2</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malak</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Gluhov</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Grizel</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Kudryashova</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Sokolova</surname>
<given-names>O. S.</given-names>
</name>
<name>
<surname>Loussouarn</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Voltage-dependent Activation in EAG Channels Follows a Ligand-Receptor rather Than a Mechanical-Lever Mechanism</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>294</volume>, <fpage>6506</fpage>&#x2013;<lpage>6521</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA119.007626</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>